Axitinib: Optimizando el tratamiento de segunda línea del cáncer renal - page 36

A4061079: Phase 1b dose‐finding study of pembrolizumab + axitinib in

line mRCC

All causality AEs

Atkins et al, ESMO 2016 Poster 773PD

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,26,27,28,29,30,31,32,33,34,35 37,38,39,40,41,42,43,44